Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015613
Filing Date
2024-11-14
Accepted
2024-11-14 07:15:22
Documents
79
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20240930x10q.htm   iXBRL 10-Q 1833606
2 EX-10.1 ocul-20240930xex10d1.htm EX-10.1 101812
3 EX-10.2 ocul-20240930xex10d2.htm EX-10.2 96692
4 EX-10.3 ocul-20240930xex10d3.htm EX-10.3 15003
5 EX-10.4 ocul-20240930xex10d4.htm EX-10.4 114662
6 EX-31.1 ocul-20240930xex31d1.htm EX-31.1 12035
7 EX-31.2 ocul-20240930xex31d2.htm EX-31.2 8483
8 EX-32.1 ocul-20240930xex32d1.htm EX-32.1 5028
9 EX-32.2 ocul-20240930xex32d2.htm EX-32.2 5039
  Complete submission text file 0001558370-24-015613.txt   7553470

Data Files

Seq Description Document Type Size
10 EX-101.SCH ocul-20240930.xsd EX-101.SCH 46532
11 EX-101.CAL ocul-20240930_cal.xml EX-101.CAL 52090
12 EX-101.DEF ocul-20240930_def.xml EX-101.DEF 213766
13 EX-101.LAB ocul-20240930_lab.xml EX-101.LAB 370169
14 EX-101.PRE ocul-20240930_pre.xml EX-101.PRE 331012
82 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20240930x10q_htm.xml XML 1144902
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 241457163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)